Journal
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 43, Issue -, Pages 21-24Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.ijid.2015.12.004
Keywords
Tuberculosis; Mycobacterium tuberculosis; Latent tuberculosis; Humoral immunity; Anti-tuberculin antibodies; T-cell proliferation
Categories
Funding
- NIH [AI49213, HL29583, HL59838, NIH F32 HD081835]
- Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute
- National Council of Science and Technology of Mexico [Conacyt SALUD 115497]
- Bristol Myers Squibb Postdoctoral Fellowship
- HT Langbert Charitable Trust Research Fund
- Cheryl Manne Fund for the Cure of MS
Ask authors/readers for more resources
Objectives: To determine the effect of anti-tuberculin antibodies in the T-cell proliferation in response to tuberculin and Candida antigens in individuals with different levels of tuberculosis (TB) risk. Methods: Sixteen high-risk TB individuals, 30 with an intermediate TB risk (group A), and 45 with a low TB risk (group B), as well as 49 control individuals, were studied. Tuberculin skin test (TST) results were analyzed and serum levels of antibodies (IgG and IgM) against purified protein derivative (PPD) were measured by ELISA. Tuberculin and Candida antigens were used to stimulate T-cell proliferation in the presence of human AB serum or autologous serum. Results: High levels of anti-tuberculin IgG antibodies were found to be significantly associated with the blocking of T-cell proliferation responses in cultures stimulated with tuberculin but not with Candida antigens in the presence of autologous serum. This phenomenon was particularly frequent in high-risk individuals with high levels of anti-tuberculin IgG antibodies in the autologous serum when compared to the other risk groups, which exhibited lower levels of anti-tuberculin antibodies. Conclusions: Although cellular immunity plays a central role in the protection against TB, humoral immunity is critical in the control of Mycobacterium tuberculosis infection in high-risk individuals with latent TB infection. (C) 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available